{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:04Z","timestamp":1781626024708,"version":"3.54.5"},"reference-count":191,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001790","name":"Ara Parseghian Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001790","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dana's Angels Research Trust"},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New Zealand Organisation of Rare Diseases"},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003181","name":"National Niemann-Pick Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK54320"],"award-info":[{"award-number":["DK54320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM1.29465"],"award-info":[{"award-number":["GM1.29465"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbalip.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:23:32Z","timestamp":1555453412000},"page":"1109-1123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease"],"prefix":"10.1016","volume":"1864","author":[{"given":"Natalie","family":"Hammond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Munkacsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Sturley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2019.04.002_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2015.11.010","article-title":"A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality","volume":"10","author":"Wadhera","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0010","first-page":"746","article-title":"Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases","volume":"5","author":"Vance","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0015","doi-asserted-by":"crossref","unstructured":"E.D. Carstea, J.A. Morris, K.G. Coleman, S.K. Loftus, D. Zhang, C. Cummings, J. Gu, M.A. Rosenfeld, W.J. Pavan, D.B. Krizman, J. Nagle, M.H. Polymeropoulos, S.L. Sturley, Y.A. Ioannou, M.E. Higgins, M. Comly, A. Cooney, A. Brown, C.R. Kaneski, E.J. Blanchette-Mackie, N.K. Dwyer, E.B. Neufeld, T.Y. Chang, L. Liscum, J.F. Strauss, 3rd, K. Ohno, M. Zeigler, R. Carmi, J. Sokol, D. Markie, R.R. O'Neill, O.P. van Diggelen, M. Elleder, M.C. Patterson, R.O. Brady, M.T. Vanier, P.G. Pentchev, D.A. Tagle, Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis, Science 277 (1997) 228\u2013231.","DOI":"10.1126\/science.277.5323.228"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","article-title":"Recommendations for the detection and diagnosis of Niemann-Pick disease type C: an update","volume":"7","author":"Patterson","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40263-018-0599-0","article-title":"Psychiatric and cognitive symptoms associated with Niemann-Pick type C disease: neurobiology and management","volume":"33","author":"Rego","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0045","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-Pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1388-1981(99)00070-0","article-title":"A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol","volume":"1438","author":"Okamura","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0055","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1073\/pnas.0530027100","article-title":"The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels","volume":"100","author":"Ko","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0060","doi-asserted-by":"crossref","unstructured":"R.E. Infante, A. Radhakrishnan, L. Abi-Mosleh, L.N. Kinch, M.L. Wang, N.V. Grishin, J.L. Goldstein, M.S. Brown, Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop, J. Biol. Chem. 283 (2008) 1064\u20131075.","DOI":"10.1074\/jbc.M707944200"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0065","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1073\/pnas.0807328105","article-title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes","volume":"105","author":"Infante","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0070","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0080","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/302626","article-title":"Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype","volume":"65","author":"Millat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0090","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/320599","article-title":"Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1","volume":"68","author":"Sun","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/324068","article-title":"Niemann-Pick disease type C: spectrum of HE1 mutations and genotype\/phenotype correlations in the NPC2 group","volume":"69","author":"Millat","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/2326409815618979","article-title":"Distinct Niemann-Pick disease type C clinical, cytological, and biochemical phenotype in an adult patient with 1 mutated, overexpressed NPC1 allele","volume":"3","author":"Jecel","year":"2015","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2008.09.046","article-title":"Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and\/or aging in the Polish population","volume":"447","author":"Erickson","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0110","doi-asserted-by":"crossref","unstructured":"D. Meyre, J. Delplanque, J.C. Chevre, C. Lecoeur, S. Lobbens, S. Gallina, E. Durand, V. Vatin, F. Degraeve, C. Proenca, S. Gaget, A. Korner, P. Kovacs, W. Kiess, J. Tichet, M. Marre, A.L. Hartikainen, F. Horber, N. Potoczna, S. Hercberg, C. Levy-Marchal, F. Pattou, B. Heude, M. Tauber, M.I. McCarthy, A.I. Blakemore, A. Montpetit, C. Polychronakos, J. Weill, L.J. Coin, J. Asher, P. Elliott, M.R. Jarvelin, S. Visvikis-Siest, B. Balkau, R. Sladek, D. Balding, A. Walley, C. Dina, P. Froguel, Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations, Nat. Genet. 41 (2009) 157\u2013159.","DOI":"10.1038\/ng.301"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0115","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1128\/JVI.00259-09","article-title":"Deficiency of Niemann-Pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal\/lysosomal compartments","volume":"83","author":"Tang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbalip.2004.08.010","article-title":"Metazoan and microbial models of Niemann-Pick Type C disease","volume":"1685","author":"Higaki","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0135","first-page":"1089","article-title":"Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C","volume":"6","author":"Lopez","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0140","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1126\/science.290.5500.2295","article-title":"Transmembrane molecular pump activity of Niemann-Pick C1 protein","volume":"290","author":"Davies","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0145","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/302620","article-title":"Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain","volume":"65","author":"Greer","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0150","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M002184200","volume":"275","author":"Davies","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0155","doi-asserted-by":"crossref","first-page":"18932","DOI":"10.1073\/pnas.1110439108","article-title":"Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding","volume":"108","author":"Deffieu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0160","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola virus entry requires the host-programmed recognition of an intracellular receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0165","doi-asserted-by":"crossref","unstructured":"X. Li, F. Lu, M.N. Trinh, P. Schmiege, J. Seemann, J. Wang, G. Blobel, 3.3 A structure of Niemann-Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport, Proc. Natl. Acad. Sci. USA 114 (2017) 9116\u20139121.","DOI":"10.1073\/pnas.1711716114"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0170","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/320606","article-title":"Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop","volume":"68","author":"Millat","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1095\/biolreprod54.4.847","article-title":"Molecular cloning and characterization of HE1, a major secretory protein of the human epididymis","volume":"54","author":"Kirchhoff","year":"1996","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0968-0004(02)02084-4","article-title":"ML \u2014 a conserved domain involved in innate immunity and lipid metabolism","volume":"27","author":"Inohara","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0185","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.0437840100","article-title":"Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease","volume":"100","author":"Friedland","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0190","series-title":"Lysosomal cholesterol export reconstituted from fragments of Niemann-Pick C1, eLife 7","author":"Trinh","year":"2018"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0195","series-title":"Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export, eLife 5","author":"Li","year":"2016"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0200","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.aag1417","article-title":"Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex","volume":"355","author":"Castellano","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0205","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1242\/jcs.02993","article-title":"Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1\/Vps4","volume":"119","author":"Ohsaki","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0210","first-page":"14","article-title":"The Niemann-Pick C1 and caveolin-1 proteins interact to modulate efflux of low density lipoprotein-derived cholesterol from late endocytic compartments","volume":"3","author":"Jelinek","year":"2014","journal-title":"J. Mol. Biochem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pmic.201500110","article-title":"Identification of lysosomal Npc1-binding proteins: Cathepsin D activity is regulated by NPC1","volume":"16","author":"Macias-Vidal","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0220","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0230","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbior.2018.08.001","article-title":"Niemann-Pick type C disease: the atypical sphingolipidosis","volume":"70","author":"Newton","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200310046","article-title":"Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution","volume":"164","author":"Malathi","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0240","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0245","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1016\/S0021-9258(18)45483-X","article-title":"Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts","volume":"262","author":"Liscum","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1083\/jcb.108.5.1625","article-title":"The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts","volume":"108","author":"Liscum","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0255","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","article-title":"A defect in cholesterol esterification in Niemann-Pick disease (type C) patients","volume":"82","author":"Pentchev","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0260","doi-asserted-by":"crossref","first-page":"31594","DOI":"10.1016\/S0021-9258(19)84073-5","article-title":"Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport","volume":"281","author":"Cheruku","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0265","doi-asserted-by":"crossref","DOI":"10.1017\/S146239940800080X","article-title":"The pathogenesis of Niemann-Pick type C disease: a role for autophagy?","volume":"10","author":"Pacheco","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0270","doi-asserted-by":"crossref","first-page":"205713","DOI":"10.1155\/2012\/205713","article-title":"Oxidative stress: a pathogenic mechanism for Niemann-Pick type C disease","volume":"2012","author":"Vazquez","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2019.04.002_bb0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.13138","article-title":"Immune dysfunction in Niemann-Pick disease type C","volume":"136","author":"Platt","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0280","first-page":"30312","article-title":"The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases","volume":"18","author":"Liu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2008.10.003","article-title":"Clinical research for rare disease: opportunities, challenges, and solutions","volume":"96","author":"Griggs","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0290","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.healthpol.2009.12.001","article-title":"The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?","volume":"95","author":"Wellman-Labadie","year":"2010","journal-title":"Health Policy"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-016-0540-x","article-title":"Fostering collaborative research for rare genetic disease: the example of Niemann-Pick type C disease","volume":"11","author":"Walkley","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0300","series-title":"Twin disorders, The Scientist 22","author":"McCook","year":"2008"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/bs.mcb.2014.10.028","article-title":"Laboratory diagnosis of Niemann-Pick disease type C: the filipin staining test","volume":"126","author":"Vanier","year":"2015","journal-title":"Method. Cell Biol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0310","doi-asserted-by":"crossref","unstructured":"F.D. Porter, D.E. Scherrer, M.H. Lanier, S.J. Langmade, V. Molugu, S.E. Gale, D. Olzeski, R. Sidhu, D.J. Dietzen, R. Fu, C.A. Wassif, N.M. Yanjanin, S.P. Marso, J. House, C. Vite, J.E. Schaffer, D.S. Ory, Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease, Sci. Transl. Med. 2 (2010) 56ra81.","DOI":"10.1126\/scitranslmed.3001417"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.steroids.2013.05.017","article-title":"LC\/ESI-MS\/MS analysis of urinary 3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease","volume":"78","author":"Maekawa","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0320","doi-asserted-by":"crossref","unstructured":"X. Jiang, R. Sidhu, L. Mydock-McGrane, F.F. Hsu, D.F. Covey, D.E. Scherrer, B. Earley, S.E. Gale, N.Y. Farhat, F.D. Porter, D.J. Dietzen, J.J. Orsini, E. Berry-Kravis, X. Zhang, J. Reunert, T. Marquardt, H. Runz, R. Giugliani, J.E. Schaffer, D.S. Ory, Development of a bile acid-based newborn screen for Niemann-Pick disease type C, Sci. Transl. Med. 8 (2016) 337ra363.","DOI":"10.1126\/scitranslmed.aaf2326"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147208","article-title":"Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease","volume":"11","author":"Marques","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0330","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/1873-3468.12196","article-title":"Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease","volume":"590","author":"Mazzacuva","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.02.030","article-title":"Determination of serum cholestane-3beta,5alpha,6beta-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease","volume":"169","author":"Kannenberg","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0340","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cca.2018.08.039","article-title":"The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency","volume":"486","author":"Deodato","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0345","first-page":"90","article-title":"Elevation of plasma lysosphingomyelin-509 and urinary bile acid metabolite in Niemann-Pick disease type C-affected individuals","volume":"15","author":"Mashima","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0350","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2018.08.007","article-title":"Diagnosis of Niemann-Pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots","volume":"126","author":"Jiang","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","article-title":"Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review","volume":"118","author":"Vanier","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13023-018-0985-1","article-title":"Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?","volume":"14","author":"Sobrido","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0365","doi-asserted-by":"crossref","unstructured":"P.G. Pentchev, M.E. Comly, H.S. Kruth, S. Patel, M. Proestel, H. Weintroub, The cholesterol storage disorder of the mutant BALB\/c mouse. A primary genetic lesion closely linked to defective esterification of exogenously derived cholesterol and its relationship to human type C Niemann-Pick disease, J. Biol. Chem. 261 (1986) 2772\u20132777.","DOI":"10.1016\/S0021-9258(17)35852-0"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0370","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1016\/S0021-9258(18)91082-3","article-title":"A genetic storage disorder in BALB\/C mice with a metabolic block in esterification of exogenous cholesterol","volume":"259","author":"Pentchev","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0375","doi-asserted-by":"crossref","first-page":"11796","DOI":"10.1016\/S0021-9258(18)80136-3","article-title":"The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one","volume":"264","author":"Liscum","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0380","series-title":"Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection, eLife 4","author":"Lu","year":"2015"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0385","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/hmg\/dds090","article-title":"Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1","volume":"21","author":"Ordonez","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-8-34","article-title":"A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin","volume":"8","author":"Bergamin","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0395","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","article-title":"Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells","volume":"2","author":"Maetzel","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0400","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/1087057114537378","article-title":"Niemann-Pick disease type C: induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy","volume":"19","author":"Yu","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0405","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0005-2760(80)90116-2","article-title":"A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase","volume":"619","author":"Pentchev","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0410","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jhered.a109635","article-title":"Sphingomyelinosis, a new mutation in the mouse: a model of Niemann-Pick disease in humans","volume":"73","author":"Miyawaki","year":"1982","journal-title":"J. Hered."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0415","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/hmg\/ddr505","article-title":"A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations","volume":"21","author":"Maue","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0420","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","article-title":"A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele","volume":"35","author":"Praggastis","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0425","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.22327","article-title":"In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C-associated liver disease","volume":"47","author":"Rimkunas","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0430","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.1073\/pnas.1112751108","article-title":"Amino acid substitution in NPC1 that abolishes cholesterol binding reproduces phenotype of complete NPC1 deficiency in mice","volume":"108","author":"Xie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0435","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/hmg\/11.24.3107","article-title":"Rescue of neurodegeneration in Niemann-Pick C mice by a prion-promoter-driven Npc1 cDNA transgene","volume":"11","author":"Loftus","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0440","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1523\/JNEUROSCI.5981-10.2011","article-title":"Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder","volume":"31","author":"Lopez","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0445","first-page":"81","article-title":"Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease","volume":"1","author":"Ko","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0450","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1093\/hmg\/ddr372","article-title":"Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration","volume":"20","author":"Yu","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0455","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.13052","article-title":"Disease models for the development of therapies for lysosomal storage diseases","volume":"1371","author":"Xu","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0460","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00334507","article-title":"Feline sphingolipidosis resembling Niemann-Pick disease type C","volume":"81","author":"Lowenthal","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1096-7192(03)00074-X","article-title":"Mutation analysis of feline Niemann-Pick C1 disease","volume":"79","author":"Somers","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0470","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann-Pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0475","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","article-title":"Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C","volume":"71","author":"Stein","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0480","doi-asserted-by":"crossref","unstructured":"C.H. Vite, J.H. Bagel, G.P. Swain, M. Prociuk, T.U. Sikora, V.M. Stein, P. O'Donnell, T. Ruane, S. Ward, A. Crooks, S. Li, E. Mauldin, S. Stellar, M. De Meulder, M.L. Kao, D.S. Ory, C. Davidson, M.T. Vanier, S.U. Walkley, Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease, Sci. Transl. Med. 7 (2015) 276ra226.","DOI":"10.1126\/scitranslmed.3010101"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0485","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jvim.14599","article-title":"Precision medicine in cats: novel Niemann-Pick type C1 diagnosed by whole-genome sequencing","volume":"31","author":"Mauler","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0495","doi-asserted-by":"crossref","unstructured":"M.S. Alam, M. Getz, K. Haldar, Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model, Sci. Transl. Med. 8 (2016) 326ra323.","DOI":"10.1126\/scitranslmed.aad9407"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0500","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm1073","article-title":"Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone","volume":"10","author":"Griffin","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0505","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0510","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0515","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","article-title":"Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment","volume":"31","author":"Aqul","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0525","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0530","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","article-title":"Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability","volume":"36","author":"Pontikis","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0535","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.43.1_Part_1.61","article-title":"The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0540","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0887-8994(94)90028-0","article-title":"Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin","volume":"10","author":"Sylvain","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0545","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1023\/A:1005650930330","article-title":"Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice","volume":"23","author":"Erickson","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0550","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneumeth.2007.09.002","article-title":"Partial blockage of sterol biosynthesis with a squalene synthase inhibitor in early postnatal Niemann-Pick type C npcnih null mice brains reduces neuronal cholesterol accumulation, abrogates astrogliosis, but may inhibit myelin maturation","volume":"168","author":"Reid","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0555","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1010588112003","article-title":"Effects of dietary cholesterol restriction in a feline model of Niemann-Pick type C disease","volume":"24","author":"Somers","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0560","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0565","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-018-0844-0","article-title":"Miglustat in Niemann-Pick disease type C patients: a review","volume":"13","author":"Pineda","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0570","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0575","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/00498250601094543","article-title":"The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat","volume":"37","author":"Treiber","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0580","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nbd.2004.05.002","article-title":"Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C","volume":"16","author":"Lachmann","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0585","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0590","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0595","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann-Pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-019-0996-6","article-title":"Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review","volume":"14","author":"Pineda","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0605","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-011-9368-7","article-title":"Gastrointestinal disturbances and their management in miglustat-treated patients","volume":"34","author":"Belmatoug","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0610","doi-asserted-by":"crossref","first-page":"21604","DOI":"10.1074\/jbc.271.35.21604","article-title":"Intracellular trafficking of cholesterol monitored with a cyclodextrin","volume":"271","author":"Neufeld","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0620","doi-asserted-by":"crossref","first-page":"19316","DOI":"10.1073\/pnas.0910916106","article-title":"Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells","volume":"106","author":"Abi-Mosleh","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0625","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/17425247.2.1.335","article-title":"Cyclodextrins in drug delivery","volume":"2","author":"Loftsson","year":"2005","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0630","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/1440-1681.12285","article-title":"Systemic administration of 2-hydroxypropyl-beta-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function","volume":"41","author":"Lopez","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0635","doi-asserted-by":"crossref","unstructured":"D.S. Ory, E.A. Ottinger, N.Y. Farhat, K.A. King, X. Jiang, L. Weissfeld, E. Berry-Kravis, C.D. Davidson, S. Bianconi, L.A. Keener, R. Rao, A. Soldatos, R. Sidhu, K.A. Walters, X. Xu, A. Thurm, B. Solomon, W.J. Pavan, B.N. Machielse, M. Kao, S.A. Silber, J.C. McKew, C.C. Brewer, C.H. Vite, S.U. Walkley, C.P. Austin, F.D. Porter, Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1\u20132 trial, Lancet 390 (2017) 1758\u20131768.","DOI":"10.1016\/S0140-6736(17)31465-4"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0640","first-page":"730","article-title":"Drug for rare disease disappoints in key trial","volume":"362","author":"Wadman","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0645","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1126\/science.354.6308.18","article-title":"Battle over rare disease drug ensnares NIH","volume":"354","author":"Wadman","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0650","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2015.07.001","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1","volume":"116","author":"Maarup","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0655","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann-Pick Type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0660","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0665","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0670","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0675","series-title":"Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer, Molecules 21","author":"Losson","year":"2016"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0680","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0685","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1074\/jbc.M116.770578","article-title":"Normalization of hepatic homeostasis in the Npc1nmf164 mouse model of Niemann-Pick type C disease treated with the histone deacetylase inhibitor Vorinostat","volume":"292","author":"Munkacsi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0690","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"Mitsiades","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0695","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","article-title":"Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0700","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.1014890108","article-title":"Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts","volume":"108","author":"Pipalia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0705","doi-asserted-by":"crossref","first-page":"23842","DOI":"10.1074\/jbc.M111.227645","article-title":"An \u201cexacerbate-reverse\u201d strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease","volume":"286","author":"Munkacsi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0710","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1194\/jlr.M072140","article-title":"Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells","volume":"58","author":"Pipalia","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0715","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nbt0313-189","article-title":"Orphazyme","volume":"31","author":"Garber","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0720","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm1021","article-title":"Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice","volume":"10","author":"Kieran","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0725","doi-asserted-by":"crossref","unstructured":"T. Kirkegaard, J. Gray, D.A. Priestman, K.L. Wallom, J. Atkins, O.D. Olsen, A. Klein, S. Drndarski, N.H. Petersen, L. Ingemann, D.A. Smith, L. Morris, C. Bornaes, S.H. Jorgensen, I. Williams, A. Hinsby, C. Arenz, D. Begley, M. Jaattela, F.M. Platt, Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses, Sci. Transl. Med. 8 (2016) 355ra118.","DOI":"10.1126\/scitranslmed.aad9823"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0730","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature08710","article-title":"Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology","volume":"463","author":"Kirkegaard","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0735","doi-asserted-by":"crossref","first-page":"19714","DOI":"10.1074\/jbc.M114.549915","article-title":"Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin","volume":"289","author":"Nakasone","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2013.08.003","article-title":"The role of heat shock proteins in Amyotrophic Lateral Sclerosis: the therapeutic potential of Arimoclomol","volume":"141","author":"Kalmar","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0745","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1567205012666141218141904","article-title":"Acute oral Bryostatin-1 administration improves learning deficits in the APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"12","author":"Schrott","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0750","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-170161","article-title":"Bryostatin effects on cognitive function and PKC\u03b5 in Alzheimer's disease Phase IIa and expanded access trials","volume":"58","author":"Nelson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0755","doi-asserted-by":"crossref","unstructured":"M. Malnar, S. Hecimovic, N. Mattsson, H. Zetterberg, Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease, Neurobiol. Dis. 72 Pt A (2014) 37\u201347.","DOI":"10.1016\/j.nbd.2014.05.033"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0760","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/cn5000309","article-title":"Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders","volume":"5","author":"Forlenza","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0765","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/11599180-000000000-00000","article-title":"Does lithium prevent Alzheimer's disease?","volume":"29","author":"Forlenza","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0770","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a treatment for Alzheimer's disease: a systematic review and meta-analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0775","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152007","article-title":"Defective cytochrome P450-catalysed drug metabolism in Niemann-Pick type C disease","volume":"11","author":"Nicoli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0785","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12688\/wellcomeopenres.11854.1","article-title":"Case report: ursodeoxycholic acid treatment in Niemann-Pick disease type C; clinical experience in four cases","volume":"2","author":"Evans","year":"2017","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0790","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.0953-816x.2000.01447.x","article-title":"In vitro effects of acetyl-DL-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig","volume":"13","author":"Vibert","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0795","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s00415-013-7016-x","article-title":"Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series","volume":"260","author":"Strupp","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0800","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1212\/WNL.0000000000002041","article-title":"Acetyl-dl-leucine in Niemann-Pick type C: a case series","volume":"85","author":"Bremova","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0805","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2013.04.004","article-title":"Monogenic diseases that can be cured by liver transplantation","volume":"59","author":"Fagiuoli","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0810","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1542\/peds.77.1.104","article-title":"Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation","volume":"77","author":"Gartner","year":"1986","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0815","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0006-291X(83)91769-2","article-title":"Bone marrow transplantation for Niemann-Pick mice","volume":"113","author":"Sakiyama","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0820","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1701826","article-title":"Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation","volume":"24","author":"Hsu","year":"1999","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 3","key":"10.1016\/j.bbalip.2019.04.002_bb0825","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1007\/s10545-010-9060-3","article-title":"Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe \u2018graft versus substrate\u2019 effect","volume":"33","author":"Bonney","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0830","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymgme.2012.11.006","article-title":"Developmental outcome post allogenic bone marrow transplant for Niemann Pick Type C2","volume":"108","author":"Breen","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0835","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI40543","article-title":"Stem cells in human neurodegenerative disorders\u2014time for clinical translation?","volume":"120","author":"Lindvall","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0840","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2005.02.029","article-title":"Neuroglial activation in Niemann-Pick Type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells","volume":"381","author":"Bae","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0845","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF03195222","article-title":"Neural stem cell implantation extends life in Niemann-Pick C1 mice","volume":"48","author":"Ahmad","year":"2007","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0850","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1292\/jvms.09-0514","article-title":"Intracerebellar transplantation of neural stem cells into mice with neurodegeneration improves neuronal networks with functional synaptic transmission","volume":"72","author":"Lee","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0855","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/jnr.21730","article-title":"Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1\u2212\/\u2212 mice","volume":"86","author":"Zhang","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0860","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2017.12.006","article-title":"In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin","volume":"643","author":"Marshall","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0865","first-page":"52","article-title":"Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1","volume":"26","author":"Chandler","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0870","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1194\/jlr.M071274","article-title":"AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease","volume":"58","author":"Xie","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0875","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddy212","article-title":"AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease","volume":"27","author":"Hughes","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0880","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2009.07.010","article-title":"Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1","volume":"36","author":"Smith","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0885","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2014.03.001","article-title":"Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice","volume":"67","author":"Williams","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0890","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0900","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13023-015-0297-7","article-title":"A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat","volume":"10","author":"Remenova","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0905","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.celrep.2013.10.042","article-title":"Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease","volume":"5","author":"Sarkar","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0910","series-title":"ROS scavenger, Ebselen, has no preventive effect in new hearing loss model using a cholesterol-chelating agent","first-page":"69","volume":"23","author":"Lee","year":"2019"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0915","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800557","article-title":"Cyclodextrin-based macromolecular systems as cholesterol-mopping therapeutic agents in Niemann-Pick Disease Type C","volume":"40","author":"Puglisi","year":"2019","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0920","doi-asserted-by":"crossref","first-page":"31750","DOI":"10.1038\/srep31750","article-title":"PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder","volume":"6","author":"Brown","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0925","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1038\/s41598-018-27926-9","article-title":"Linear cyclodextrin polymer prodrugs as novel therapeutics for Niemann-Pick type C1 disorder","volume":"8","author":"Kulkarni","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0930","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/AUD.0b013e3182a362b8","article-title":"Auditory phenotype of Niemann-Pick disease, type C1","volume":"35","author":"King","year":"2014","journal-title":"Ear Hearing"},{"key":"10.1016\/j.bbalip.2019.04.002_bb0935","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fncel.2017.00355","article-title":"Cyclodextrins and iatrogenic hearing loss: new drugs with significant risk","volume":"11","author":"Crumling","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0940","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.jnatprod.8b00314","article-title":"GEX1A, a polyketide from Streptomyces chromofuscus, corrects the cellular defects associated with Niemann-Pick type C1 in human fibroblasts","volume":"81","author":"Granatosky","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0945","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/hmg\/ddy117","article-title":"High-content screen for modifiers of Niemann-Pick type C disease in patient cells","volume":"27","author":"Pugach","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0950","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1096\/fj.201601041R","article-title":"FTY720\/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts","volume":"31","author":"Newton","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2019.04.002_bb0955","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1073110516654133","article-title":"Screening of newborns for disorders with high benefit-risk ratios should be mandatory","volume":"44","author":"Kelly","year":"2016","journal-title":"J. Law Med. Ethics"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198119300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198119300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:03:04Z","timestamp":1761386584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198119300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":191,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1388198119300496"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.04.002","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}